Medical Cannabis for Restless Legs Syndrome — Switzerland 2026
In restless legs syndrome (RLS), patients often report immediate relief on cannabis — documented in a French study. A fraction of the price for members.
In RLS, inhaled cannabis (Megelin 2017, n=6) abolishes symptoms within minutes in all cases — small but highly significant series. Add-on to dopamine agonists (pramipexole, rotigotine) or gabapentin. In augmentation, cannabis can enable dose reduction. CannabisClub members: 50 CHF flat instead of 190.
What the studies show
Megelin 2017 (Sleep Med): 6 refractory RLS patients, inhaled cannabis — all report complete or marked relief within minutes.
Ghorayeb 2020 (survey, n=48): 44 % of RLS patients on cannabis report very good control, 90 % sleep improvement.
Preparations & dosing
Bediol or Bedrocan flower vaporised, 0.05–0.15 g at symptom onset in the evening.
Dronabinol 2.5–5 mg at night as slower but longer alternative.
Save as a CannabisClub member
External consult 190 CHF, member 50 CHF flat. Quarterly follow-up: 560 CHF/year saved.
Registration is free, 2 minutes.
FAQ
Does cannabis replace my dopamine agonists?
Rarely completely — but can enable dose reduction in augmentation. Always with a neurologist.
What does membership save?
50 CHF instead of 190 CHF per consult, quarterly 560 CHF/year. Registration free.
Does insurance cover cannabis for RLS?
Rarely — only in resistance after failure of at least two standard therapies. Art. 71a HIO required.
Cannabis for Restless Legs Syndrome — Prescription Switzerland 2026 (Members 50 CHF)